OVID - Ovid Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart

OVID is currently covered by 6 analysts with an average price target of $5.25. This is a potential upside of $3.05 (138.64%) from yesterday's end of day stock price of $2.2.

Ovid Therapeutics's activity chart (see below) currently has 67 price targets and 72 ratings on display. The stock rating distribution of OVID is 100% BUY.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 10.81% of the time, taking 50.78 days on average.

Highest price target for OVID is $7, Lowest price target is $4, average price target is $5.25.

Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 11-Sep-2026. First documented stock forecast 30-May-2017.

Currently out of the existing stock ratings of OVID, 13 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 29-Apr-2024

$5

$2.8 (127.27%)

$4

2 months 10 days ago
(11-Sep-2026)

3/14 (21.43%)

$2.31 (85.87%)

178

Buy Since 09-Oct-2025

$5

$2.8 (127.27%)

$5

6 months 8 days ago
(13-May-2026)

0/3 (0%)

$2.2 (78.57%)

Buy Since 05-Apr-2024

$7

$4.45 (174.51%)

$7

7 months 6 days ago
(15-Apr-2026)

0/4 (0%)

$4.24 (153.62%)

Buy Since 16-Nov-2025

$5

$2.8 (127.27%)

$5

7 months 6 days ago
(15-Apr-2026)

0/2 (0%)

$2.24 (81.16%)

Buy Since 20-Dec-2023

$4

$1.8 (81.82%)

7 months 26 days ago
(26-Mar-2026)

0/5 (0%)

$1.54 (62.60%)

Show more analysts

Please expand the browser size to see the chart

What is OVID (Ovid Therapeutics) average time for price targets to be met?

On average it took 51 days for the stock forecasts to be reached, with an average price target met ratio of 10.81%.

Which analyst most recently updated their price target on OVID (Ovid Therapeutics)?

Raghuram Selvaraju

Which analyst has the most public recommendations on OVID (Ovid Therapeutics)?

Raghuram Selvaraju works at HC WAINWRIGHT and has 5 price targets and 2 ratings on OVID

Which analyst is the currently most bullish on OVID (Ovid Therapeutics)?

Tyler Van Buren with the highest potential upside of $11.8

Which analyst is the currently most reserved on OVID (Ovid Therapeutics)?

Yigal Nochomovitz with the lowest potential downside of -$1
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?